| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.00098 | 1 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.00081 | 1 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.0046 | 1 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | -0.0031 | 1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.0008 | 1 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.00084 | 1 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00053 | 1 |